Noro-Moseley Partners

Noro-Moseley Partners (NMP) is a long-standing venture capital firm based in Atlanta, Georgia, with a rich history dating back to its founding in 1983. The firm primarily focuses on early-growth stage companies within the technology and healthcare sectors, demonstrating a consistent commitment to fostering innovation in these critical industries. NMP is known for its hands-on approach, often leading or co-leading investment rounds and providing strategic guidance to its portfolio companies.

Over its four-decade tenure, Noro-Moseley Partners has built an extensive portfolio, having invested in more than 200 promising startups and early-growth stage companies. This deep experience in the venture capital landscape allows them to identify and nurture high-potential businesses across various sub-sectors within technology, such as enterprise software and fintech, and healthcare, including health IT and medical devices. Their long-term perspective and regional focus on the Southeast United States, while not exclusive, have made them a significant player in the region's entrepreneurial ecosystem.

NMP typically deploys initial capital ranging from $3 million to $10 million, with the capacity for substantial follow-on investments as their portfolio companies achieve key milestones and scale. The firm recently closed its ninth fund, Noro-Moseley Partners IX, at $150 million in 2022, underscoring their continued ability to attract significant institutional capital. With over $1 billion in total capital raised across all its funds, NMP maintains a robust financial foundation to support its investment strategy and drive the growth of its portfolio.